Monitor for actual sales via future Form 4 or Form 144 filings; this notice alone is not a sale and is typical for institutional holders managing positions. Given the small size relative to market cap, significant price impact is unlikely unless part of a broader exit pattern.
Price Chart
Executive Summary
OrbiMed Israel GP Ltd., the general partner of OrbiMed Israel Partners Limited Partnership, filed a Form 144 to notify intent to sell up to 64,242 shares of Adicet Bio, Inc. (ACET) common stock. The filing is a routine notice of potential sale by an institutional holder and does not confirm that the sale will occur.
Key Facts
- Reporting entity: OrbiMed Israel GP Ltd., acting as general partner for OrbiMed Israel Partners Limited Partnership
- Number of shares proposed for sale: 64,242
- Security type: Common stock
- Filing date: April 7, 2026
- Method of sale: Not specified in filing
- Relationship: Institutional shareholder, not an officer or director of ACET
Financial Impact
Approximately $2.6 million based on current market price ($41.31 per share), representing a small fraction of ACET's $66M market cap
Risk Factors
- Potential downward pressure on stock if sale is executed near-term, especially given ACET's low market cap
- Perception of reduced confidence by a major institutional holder, though OrbiMed remains invested
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0000947871-26-000413 |
| Document: 0000947871-26-000413-index.html | 0000947871-26-000413 |
| Document: 0000947871-26-000413.txt | 0000947871-26-000413 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 3d ago | SC 13G | $4.03 | awaiting T+20 | — | $3.99 (−0.98%) |
Sep 28, 2026 28d ago | 8-K | $6.35 $3.94 | ▼ −37.95% | ▼ −37.92% | $3.99 (−37.17%) |
Sep 1, 2026 7w ago | 8-K | $9.26 $7.12 | ▼ −23.11% | ▼ −24.29% | $3.99 (−56.91%) |
May 20, 2026 22w ago | 10-K/A | $7.89 $8.23 | ▲ +4.31% | ▲ +3.98% | $3.99 (−49.43%) |
May 13, 2026 23w ago | 8-K | $8.41 $8.05 | ▼ −4.28% | ▼ −3.42% | $3.99 (−52.56%) |
Apr 8, 2026 28w ago | 144 | $6.86 $8.55 | ▲ +24.64% | ▲ +17.07% | $3.99 (−41.84%) |
Apr 7, 2026 28w ago | 144 | $6.55 $8.51 | ▲ +29.92% | ▲ +21.38% | $3.99 (−39.08%) |
Mar 24, 2026 30w ago | EFFECT | $6.69 $8.31 | ▲ +24.22% | ▲ +15.31% | $3.99 (−40.36%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers